Standout Papers

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL... 2008 2026 2014 2020 572
  1. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease (2008)
    Norihiro Nishimoto, Kimio Terao et al. Blood

Immediate Impact

1 by Nobel laureates 9 from Science/Nature 70 standout
Sub-graph 1 of 20

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
CAR immune cells: design principles, resistance and the next generation
2023 StandoutNature
2 intermediate papers

Works of Kimio Terao being referenced

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
2008 Standout

Author Peers

Author Last Decade Papers Cites
Kimio Terao 251 160 217 235 20 828
Gianni Binotto 215 166 236 146 34 760
Joel C. Silverfield 145 247 173 537 13 976
Francesca Spanò 138 109 356 266 25 935
Maher Issa 164 178 118 477 26 917
M. Campion 165 71 94 122 20 697
Alba Erra 85 107 153 413 25 743
Linchong Su 96 68 292 175 37 741
Michael Binks 166 62 237 384 29 906
Luca Petricca 54 89 161 284 38 713
H Gunn 207 125 282 111 25 881

All Works

Loading papers...

Rankless by CCL
2026